Skip to main content

Table 1 Summary of thymic clear cell carcinoma reported on Pubmed

From: Clinicopathologic characteristics of thymic clear cell carcinoma: a case report with literature review

Literature

Age/gender

Chief complaint

Immunohistochemistry and special stain

Treatment

DFS

MS

Snover et al.

42/M

Asymptomatic

PAS (+)

TT

CR

108

WS

Wolfe et al.

33/M

Fever

Fatigue

Weight loss

PAS (+)

Muci (−)

CR

0.5

Buttock

Stephens et al.

72/M

Asymptomatic

LMK (+)

Muci, PAS, CEA (−)

TT

CR

12*

 

Kuo et al.

64/M

Dyspnea

PAS, LMK (+)

None

3

DOD

Truong et al.

69/M

Chest pain

LMK, EMA (+)

Muci, Vim, PLAP (−)

TT

RT

36

Lung

Hasserjian et al.

36/M

Asymptomatic

PAS, LMK, HMK, Vim (+)

Muci, EMA, CEA, PLAP (−)

TT

CR

24

DOD

 

58/F

Asymptomatic

PAS, LMK, HMK, PLAP (+)

Muci, Vim, EMA, CEA (−)

TT

RT

20

DOD

 

52/F

Chest pain

PAS, LMK, HMK (+)

Muci, Vim, EMA, CEA, PLAP (−)

TT

CR

12

Spine

 

84/F

Asymptomatic

PAS, LMK, HMK (+)

Muci, Vim, EMA, CEA, PLAP (−)

TT

1.5

DOD

 

37/F

NA

Muci (−)

TT

RT

72*

 
 

50/M

Chest pain

PAS (+)

Muci, EMA, CEA, PLAP (−)

CR

4

DOD

 

62/M

NA

PAS, LMK, HMK, EMA, CEA (+)

Muci, Vim, PLAP (−)

TT

RT

7*

 
 

36/F

Dyspnea

Chest pain

PAS, LMK, HMK, EMA, PLAP (+)

Muci (−)

CR

7

DOD

Okuda et al.

59/M

Dyspnea

CK, EMA (+)

CR

6*

 

Nakano et al.

42/M

Asymptomatic

CK, CEA (+)

Vim, PLAP (−)

TT

CR

12

Brain

Lale et al.

66/F

Chest pain

Dyspnea

CK7, EMA, PAS (+)

CK20, Muci, P63 (−)

RT

TT

NA

NA

Bertocchi et al.

36/M

Asymptomatic

CK, AE/AE3 (+)

CK5/6, p63, EMA, PLAP (−)

TT

CR

24*

 

Dai et al.

50/F

Asymptomatic

CK, PAS, p63, CK19 (+)

CK7, Vim, PLAP, Pax-8, PTH, (−)

TT

CR

12*

 

Porubsky et al.

66/M

NA

P40 (+)

HMK, PAX8 (−)

NA

NA

NA

 

52/F

NA

P40, PAX8 (+)

HMK, (+)/(−)

NA

NA

NA

 

64/M

NA

P40, PAX8 (+)

HMK (−)

NA

NA

NA

Salgueiro et al.

61/F

Chest pain

Dyspnea

AE1/AE3, CK5/6, CK7 (+)

None

2

DOD

Present case

45/M

Chest tightness

AE1/AE3, CK18, EMA, PAX8, Vimentin (+)

CK19 (−)

TT

RT

CR

20

Adrenal gland

  1. DFS, disease free survival; MS, metastasis site; M, male; F, female; NA, not available; TT, thymectomy; CT, chemotherapy; RT, radiotherapy; DOD, dead of disease; WS, widespread; PAS, periodic acid Schiff; LMK, low molecular weight keratin; HMK, high molecular weight keratin; EMA, epithelial membrane antigen; CK, cytokeratin; Vim, vimentin; PLAP, placental alkaline phosphatase; CEA, carcinoembryonic antigen; PAX8, paired box protein pax-8
  2. *Disease free survival up to the last follow-up